Alnylam Pharmaceuticals | ALNY - PE Price to Earnings


Alnylam Pharmaceuticals reported 80.04 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amgen 19.84 5.47 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 28.09 807.38 Mar/2026
Novartis 21.36 3.57 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Sanofi 20.87 5.12 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
Takeda 46.52 188.53 Mar/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Vertex Pharmaceuticals 25.82 0.33 Mar/2026
Xencor 29.92 3.22 Sep/2022